Hyaluronan peroxidation is required for normal synovial function: An hypothesis

Medical Hypotheses

Volumn 82, Issue 6, 2014, Pages 662-666

  Juranek, I ^a   Stern, R ^b   Soltes L ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b Touro College of Osteopathic Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; HYALURONIC ACID; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE;

ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; DOWN REGULATION; FENTON REACTION; HYPEREMIA; HYPOTHESIS; ISCHEMIA; MITOCHONDRION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PEROXIDATION; PHYSICAL ACTIVITY; SYNOVIAL FLUID; SYNOVIUM; BIOLOGICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; JOINT; METABOLISM; PHYSIOLOGY; TIME;

HUMANS; HYALURONIC ACID; HYDROGEN PEROXIDE; JOINTS; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; REACTIVE OXYGEN SPECIES; SYNOVIAL MEMBRANE; TIME FACTORS;

EID: 84899641348     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2014.02.024     Document Type: Article

References (44)

1. Stern R., Asari A.A., Sugahara K.N. Hyaluronan fragments: an information-rich system. Eur J Cell Biol 2006, 85(8):699-715.
2. Iwanaga T., Shikichi M., Kitamura H., Yanase H., Nozawa-Inoue K. Morphology and functional roles of synoviocytes in the joint. Arch Histol Cytol 2000, 63(1):17-31.
3. Archer C.W., Francis-West P. The chondrocyte. Int J Biochem Cell Biol 2003, 35(4):401-404.
4. Chen F.H., Rousche K.T., Tuan R.S. Technology insight: adult stem cells in cartilage regeneration and tissue engineering. Nat Clin Pract Rheumatol 2006, 2(3):373-382.
5. Gibson J.S., Milner P.I., White R., Fairfax T.P., Wilkins R.J. Oxygen and reactive oxygen species in articular cartilage: modulators of ionic homeostasis. Pflugers Arch 2008, 455(4):563-573.
6. Fermor B, Christensen SE, Youn I, Cernanec JM, Davies CM, Weinberg JB. Oxygen, nitric oxide and articular cartilage. Eur Cell Mater 2007;13(11):56-65.
7. Pfander D., Gelse K. Hypoxia and osteoarthritis: how chondrocytes survive hypoxic environments. Curr Opin Rheumatol 2007, 19(5):457-462.
8. Seol J.W., Lee H.B., Lee Y.J., Lee Y.H., Kang H.S., Kim I.S., et al. Hypoxic resistance to articular chondrocyte apoptosis - a possible mechanism of maintaining homeostasis of normal articular cartilage. FEBS J 2009, 276(24):7375-7385.
9. Heywood H.K., Lee D.A. Low oxygen reduces the modulation to an oxidative phenotype in monolayer-expanded chondrocytes. J Cell Physiol 2010, 222(1):248-253.
10. Yudoh K., van Trieu N., Nakamura H., Hongo-Masuko K., Kato T., Nishioka K. Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function. Arthritis Res Ther 2005, 7(2):380-391.
11. Hirao M., Tamai N., Tsumaki N.H., Myoui A. Oxygen tension regulates chondrocyte differentiation and function during endochondral ossification. J Biol Chem 2006, 281(41):31079-31092.
12. Cernanec J.M., Weinberg J.B., Batinic-Haberle I., Guilak F., Fermor B. Influence of oxygen tension on interleukin 1-induced peroxynitrite formation and matrix turnover in articular cartilage. J Rheumatol 2007, 34(2):401-407.
13. Rees M.D., Kennett E.C., Whitelock J.M., Davies M.J. Oxidative damage to extracellular matrix and its role in human pathologies. Free Radical Biol Med 2008, 44(12):1973-2001.
14. Grishko V., Xu M., Ho R., Mates A., Watson S., Kim J.T., et al. Effects of hyaluronic acid on mitochondrial function and mitochondria-driven apoptosis following oxidative stress in human chondrocytes. J Biol Chem 2009, 284(14):9132-9139.
15. Scott J.L., Gabrielides C., Davidson R.K., Swingler T.E., Clark I.M., Wallis G.A., et al. Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease. Ann Rheum Dis 2010, 69(8):1502-1510.
16. Ziskoven C., Jäger M., Kircher J., Patzer T., Bloch W., Brixius K., et al. Physiology and pathophysiology of nitrosative and oxidative stress in osteoarthritic joint destruction. Can J Physiol Pharmacol 2011, 89(7):455-466.
17. Baur A., Henkel J., Bloch W., Treiber N., Scharffetter-Kochanek K., Brüggemann G.P., et al. Effect of exercise on bone and articular cartilage in heterozygous manganese superoxide dismutase (SOD2) deficient mice. Free Radical Res 2011, 45(5):550-558.
18. Laurent T.C., Laurent U.B., Fraser J.R. Serum hyaluronan as a disease marker. Ann Med 1996, 28(3):241-253.
19. Fraser J.R., Laurent T.C., Laurent U.B. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 1997, 242(1):27-33.
20. Šoltés L., Stankovská M., Kogan G., Gemeiner P., Stern R. Contribution of oxidative-reductive reactions to high-molecular-weight hyaluronan catabolism. Chem Biodivers 2005, 2(9):1242-1245.
21. Rychly J., Šoltés L., Stankovská M., Janigová I., Csomorová K., Sasinková V., et al. Unexplored capabilities of chemiluminescence and thermoanalytical methods in characterization of intact and degraded hyaluronans. Polym Degrad Stabil 2006, 91:3174-3184.
22. Kogan G, Šoltés L. Hyaluronan, A high-molar-mass messenger reporting on the status of synovial joints: part i. physiological status. In: Pearce EM, Zaikov GE, Kirshenbaum G, editors. New steps in chemical and biochemical physics. Pure and applied science. New York: Nova Science Publishers; 2010. p. 125-35.
23. Šoltés L. Hyaluronan, A high-molar-mass messenger reporting on the status of synovial joints: part II. Pathophysiological status. In: Pearce EM, Zaikov GE. Kirshenbaum G, editors. New steps in chemical and biochemical physics. pure and applied science. New York: Nova Science Publishers; 2010. p. 137-52.
24. Valachová K., Hrabárová E., Priesolová E., Nagy M., Baňasová M., Juránek I., et al. Free-radical degradation of high-molecular-weight hyaluronan induced by ascorbate plus cupric ions. Testing of bucillamine and its SA981-metabolite as antioxidants. J Pharm Biomed Anal 2011, 56(3):664-670.
25. Šoltés L, Valachová K, Mendichi R, Kogan G, Arnhold J, Gemeiner P. Solution properties of high-molar-mass hyaluronans: the biopolymer degradation by ascorbate. Carbohydr Res 2007;342(8):1071-7.
26. Hashimoto K., Fukuda K., Yamazaki K., Yamamoto N., Matsushita T., Hayakawa S., et al. Hypoxia-induced hyaluronan synthesis by articular chondrocytes: the role of nitric oxide. Inflamm Res 2006, 55(2):72-77.
27. Šoltés L., Kogan G. Impact of transition metals in the free-radical degradation of hyaluronan biopolymer. Kinetics and thermodynamics for chemistry and biochemistry 2009, vol. 2:181-199. Nova Science Publishers, New York.
28. Yamada K., Nakamura T., Utsumi H. Enhanced intraarticular free radical reactions in a adjuvant arthritis rats. Free Radical Res 2006, 40(5):455-460.
29. Panasyuk A., Frati E., Ribault D., Mitrovic D. Effect of reactive oxygen species on the biosynthesis and structure of newly synthesized proteoglycans. Free Radical Biol Med 1994, 16(2):157-167.
30. Blanco F.J., López-Armada M.J., Maneiro E. Mitochondrial dysfunction in osteoarthritis. Mitochondrion 2004, 4(5-6):715-728.
31. Niki E. Lipid peroxidation: physiological levels and dual biological effects. Free Radical Biol Med 2009, 47(5):469-484.
32. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 39(1):44-84.
33. Janssen-Heininger Y.M., Mossman B.T., Heintz N.H., Forman H.J., Kalyanaraman B., Finkel T., et al. A Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radical Biol Med 2008, 45(1):1-17.
34. Forman H.J. Signal transduction and reactive species. Free Radical Biol Med 2009, 47(9):1237-1238.
35. Thomas D.D., Ridnour L.A., Isenberg J.S., Flores-Santana W., Switzer C.H., Donzelli S. The chemical biology of nitric oxide: implications in cellular signaling. Free Radical Biol Med 2008, 45(1):18-31.
36. Winterbourn C.C., Hampton M.B. Thiol chemistry and specificity in redox signaling. Free Radical Biol Med 2008, 45(5):549-561.
37. Forman H.J., Maiorino M., Ursini F. Signaling functions of reactive oxygen species. Biochemistry 2010, 49(5):835-842.
38. Juránek I., Bezek S. Controversy of free radical hypothesis: reactive oxygen species - cause or consequence of tissue injury?. Gen Physiol Biophys 2005, 24(3):263-278.
39. Juránek I., Horáková Ľ., Račková L., Štefek M. Antioxidants in treating pathologies involving oxidative damage: an update on medicinal chemistry and biological activity of stobadine and related pyridoindoles. Curr Med Chem 2010, 17(6):552-570.
40. Juránek I., Račková L., Štefek M. Stobadine - an indole type alternative to the phenolic antioxidant reference trolox. Biochemistry 2012, 443-452. Intech, Rijeka. D. Ekinci (Ed.).
41. Arii K., Kumon Y., Ikeda Y., Suehiro T., Hashimoto K. Edaravone inhibits rheumatoid synovial cell proliferation and migration. Free Radical Res 2006, 40(2):121-125.
42. Juránek I., Šoltés L. Reactive oxygen species in joint physiology: possible mechanism of maintaining hypoxia to protect chondrocytes from oxygen excess via synovial fluid hyaluronan peroxidation. Kinetics, catalysis and mechanism of chemical reactions 2012, 1-10. Nova Science Publishers, New York. R.M. Islamova, S.V. Kolesov, G.E. Zaikov (Eds.).
43. Juránek I., Bačiak L. Cerebral hypoxia-ischemia: focus on the use of magnetic resonance I imaging and spectroscopy in research on animals. Neurochem Int 2009, 54(8):471-480.
44. Trattnig S., Welsch G.H., Juras V., Szomolanyi P., Mayerhoefer M.E., Stelzeneder D., et al. 23Na MR imaging at 7T after knee matrix-associated autologous chondrocyte transplantation preliminary results. Radiology 2010, 257(1):175-184.